Susquehanna Fundamental Investments, LLC Medpace Holdings, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $24,801 - $29,857	-106 Reduced 0.43%	24,264 $5.88 Million
Q2 2023 Aug 11, 2023	SELL	$187.26 - $240.17 $3.46 Million - $4.44 Million	-18,496 Reduced 43.15%	24,370 $5.85 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $3.71 Million - $5.5 Million	24,264 Added 130.44%	42,866 $9.11 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $3.74 Million - $4.7 Million	-25,776 Reduced 58.08%	18,602 $2.92 Million
Q1 2022 May 16, 2022	BUY	$138.87 - $214.31 $2.33 Million - $3.6 Million	16,811 Added 60.98%	44,378 $7.26 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $1.69 Million - $2.1 Million	9,231 Added 50.34%	27,567 $6 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $3.12 Million - $3.63 Million	18,336 New	18,336 $3.47 Million
Q2 2021 Aug 11, 2021	SELL	$158.62 - $194.3 $2.65 Million - $3.25 Million	-16,738 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$109.38 - $149.19 $19,688 - $26,854	180 Added 1.09%	16,738 $2.33 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $1.13 Million - $1.58 Million	16,558 New	16,558 $1.54 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.